1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legislation

PCPC Sits Down With HBW Insight: Preemption, California Latest, Microbeads In China, More

 
• By Ryan Nelson

In a pause from the trade group’s 2020 annual meeting in Palm Beach, FL, PCPC senior executives spoke with HBW Insight about legislative priorities and challenges at the federal and state levels, emerging microplastic regulations and whether industry and consumers have a “trust problem.”

Business man showing pie chart in color background

Top execs from the Personal Care Products Council sat down with HBW Insight on 3 March to discuss some of the biggest policy and regulatory concerns facing the cosmetics industry in 2020 and beyond.

In a pause from the trade group’s 2020 annual meeting in Palm Beach, FL, PCPC leadership offered updates and perspective...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By Lauren Nardella

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.

Sunscreen Regulation Reforms Still Could Hitch Ride On Senate OMUFA Reauthorization Bill

As stakeholders and lawmakers pin their hopes on OMUFA reauthorization as a vehicle for enacting sunscreen regulatory changes, Senate version of the bill could be the ticket after a sunscreen-specific amendment withdrawn in the House.

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 
• By Malcolm Spicer

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

More from Policy & Regulation

PCPC: US Sunscreen Regs, State Recycling Laws A Burden For Trade

 
• By Lauren Nardella

The Personal Care Products Council identifies sunscreen regulations among federal laws that place US industry at a competitive disadvantage, in comments to the Federal Trade Commission and the US Department of Justice Antitrust Division.

Producers Sue Oregon Over ‘Crushing’ EPR Recycling Law, Call It Unconstitutional

 
• By Eileen Francis

A national wholesalers’ trade group is suing Oregon, claiming its EPR law, which requires producers to register, report packaging data and pay fees, is unconstitutional and overly burdensome.

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By Lauren Nardella

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.